Predictive Value of the Serum RASSF10 Promoter Methylation Status in Gastric Cancer

Journal of International Medical Research - United Kingdom
doi 10.1177/0300060519848924
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

The Diagnosis Value of Promoter Methylation of UCHL1 in the Serum for Progression of Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Prognostic or Predictive Value of MGMT Promoter Methylation in Gliomas Depends on IDH1 Mutation

Neurology
Neurology
2013English

The Expression and Promoter Hypermethylation Status of MGMT, RASSF1A in Gastric Cancer

World Journal of Cancer Research
2014English

The Prognostic Value of BRCA1 Promoter Methylation in Early Stage Triple Negative Breast Cancer

journal of Cancer Therapeutics and Research
2014English

Correlation Between the Methylation of SULF2 and WRN Promoter and the Irinotecan Chemosensitivity in Gastric Cancer

BMC Gastroenterology
MedicineGastroenterology
2013English

The Potential Predictive Value of Serum srCaS1 Levels for Overall Survival in Endometrial Cancer

Ginekologia Polska
GynecologyObstetrics
2019English

Predictive Value of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in the Diagnosis of Gastric Cancer

Clinical and Investigative Medicine
Medicine
2014English

Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status

OncoTargets and Therapy
OncologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy